BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6199521)

  • 1. Yolk sac carcinoma: an immunohistochemical and clinicopathologic review.
    Kramer SA; Wold LE; Gilchrist GS; Svensson J; Kelalis PP
    J Urol; 1984 Feb; 131(2):315-8. PubMed ID: 6199521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of infantile testicular cancer: dissection of paraaortic lymph node involvement indicated by gradual rise in serum alpha-fetoprotein after orchiectomy].
    Takeuchi T; Kuriyama M; Saito A; Chang PK; Kanematsu M; Ban Y; Nishiura T; Tanaka T
    Hinyokika Kiyo; 1985 Sep; 31(9):1643-8. PubMed ID: 2417467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yolk sac tumor of the testicle: is retroperitoneal lymph node dissection necessary?
    Homsy Y; Arrojo-Vila F; Khoriaty N; Demers J
    J Urol; 1984 Sep; 132(3):532-6. PubMed ID: 6206242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
    Morinaga S; Ojima M; Sasano N
    Cancer; 1983 Oct; 52(7):1281-9. PubMed ID: 6192898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminoma with elevated human chorionic gonadotropin. The case for retroperitoneal lymph node dissection.
    Pritchett TR; Skinner DG; Selser SF; Kern WH
    Urology; 1985 Apr; 25(4):344-6. PubMed ID: 2580384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The place of surgery in the treatment of seminomatous testicular tumors.
    Smith RB
    Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of testicular tumors.
    Catalona WJ
    Surg Clin North Am; 1982 Dec; 62(6):1119-27. PubMed ID: 6184788
    [No Abstract]   [Full Text] [Related]  

  • 9. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of yolk sac carcinoma of the testis clinical stage I: lymphadenectomy vs. no lymphadenectomy.
    Pow-Sang JE; Benavente V; Pow-Sang JM
    Prog Clin Biol Res; 1989; 303():791-8. PubMed ID: 2780673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
    Walt H; Arrenbrecht S; DeLozier-Blanchet CD; Keller PJ; Nauer R; Hedinger CE
    Cancer; 1986 Jul; 58(1):139-46. PubMed ID: 2423223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
    Eglen DE; Ulbright TM
    Am J Clin Pathol; 1987 Sep; 88(3):328-32. PubMed ID: 2443003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical analysis of management of pediatric testicular germ cell tumors.
    Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
    Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular yolk sac and embryonal carcinomas in pediatric patients: comparative immunohistochemical and clinicopathologic study.
    Wold LE; Kramer SA; Farrow GM
    Am J Clin Pathol; 1984 Apr; 81(4):427-35. PubMed ID: 6367423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
    Roth LM; Panganiban WG
    Cancer; 1976 Feb; 37(2):812-20. PubMed ID: 56218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
    Ann Intern Med; 1979 Mar; 90(3):373-85. PubMed ID: 85422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
    Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
    Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of testicular yolk sac carcinoma in the young child.
    Kaplan WE; Firlit CF
    J Urol; 1981 Nov; 126(5):663-4. PubMed ID: 7299932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
    Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.